Richard S. Levy is Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL). They have made 13 open-market trades across 4 companies since 2010, most recently 2026-08-01.
5 open-market purchases totalling $254K since 2017, against 8 sales. Across 5 scored buys the stock is up 105.8% at ninety days, and 95.2 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 80% | 80% |
| Avg Move | -1.9% | +45.7% | +105.8% |
| Alpha | -2.5% | +41.7% | +95.2% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDGL | SELL · 10b5-1 | 2026-05-22 | 2026-05-22 | $515.44 | $2.9M | -3.8% | +0.4% | +1.4% |
| MDGL | SELL · 10b5-1 | 2025-11-13 | 2025-11-14 | $520.65 | $8.5M | +14.5% | +6.8% | -9.8% |
| TARA | BUY | 2025-05-14 | 2025-05-19 | $3.19 | $64K | -11.1% | -12.9% | -5.8% |
| MDGL | SELL · 10b5-1 | 2024-11-07 | 2024-11-08 | $350.00 | $1.8M | -11.3% | -10.9% | -7.6% |
| MDGL | SELL · 10b5-1 | 2024-11-01 | 2024-11-05 | $300.71 | $2.7M | -15.5% | -8.4% | -4.7% |
| MDGL | SELL · 10b5-1 | 2024-04-01 | 2024-04-03 | $257.40 | $4.1M | -5.3% | -6.0% | +11.2% |
| MDGL | SELL | 2023-01-17 | 2023-01-19 | $293.29 | $12.4M | -4.8% | -4.6% | -3.2% |
| KOD | BUY | 2020-03-20 | 2020-03-24 | $44.33 | $44K | -10.3% | +1.1% | +22.9% |
| MDGL | BUY | 2017-08-23 | 2017-08-24 | $16.12 | $32K | +1.4% | +97.6% | +184.7% |
| MDGL | BUY | 2017-08-22 | 2017-08-23 | $16.12 | $57K | +3.8% | +104.1% | +157.8% |
| MDGL | BUY | 2017-08-21 | 2017-08-22 | $15.88 | $56K | +6.8% | +38.6% | +169.6% |
| INCY | SELL | 2016-01-06 | 2016-01-08 | $101.86 | $401K | -23.1% | -26.1% | -17.2% |
| INCY | SELL | 2016-01-06 | 2016-01-08 | $101.86 | $401K | -23.1% | -26.1% | -17.2% |
| INCY | SELL · 10b5-1 | 2015-12-07 | 2015-12-09 | $106.18 | $418K | -26.4% | -11.0% | -33.2% |
| INCY | SELL · 10b5-1 | 2015-11-06 | 2015-11-10 | $116.51 | $459K | -26.4% | -3.0% | -33.4% |
| INCY | SELL · 10b5-1 | 2015-10-06 | 2015-10-08 | $122.29 | $481K | -26.4% | -3.0% | -4.0% |
| INCY | SELL · 10b5-1 | 2015-09-11 | 2015-09-15 | $130.00 | $559K | -26.4% | -3.0% | -3.0% |
| INCY | SELL · 10b5-1 | 2015-09-08 | 2015-09-10 | $118.90 | $468K | -26.4% | -3.0% | -3.0% |
| INCY | SELL · 10b5-1 | 2015-08-06 | 2015-08-10 | $111.95 | $441K | -26.4% | -3.0% | -3.0% |
| INCY | SELL · 10b5-1 | 2015-07-15 | 2015-07-16 | $120.00 | $8.4M | -26.4% | -3.0% | -3.0% |
| INCY | SELL · 10b5-1 | 2015-07-06 | 2015-07-08 | $107.00 | $421K | -26.4% | -3.0% | -3.0% |
| INCY | SELL · 10b5-1 | 2015-06-19 | 2015-06-23 | $108.13 | $2.2M | -26.4% | -3.0% | -3.0% |
| INCY | SELL · 10b5-1 | 2015-06-08 | 2015-06-10 | $107.58 | $424K | -26.4% | -3.0% | -3.0% |
| INCY | SELL · 10b5-1 | 2015-05-06 | 2015-05-08 | $99.43 | $737K | -26.4% | -3.0% | -3.0% |
| INCY | SELL · 10b5-1 | 2015-04-06 | 2015-04-08 | $88.77 | $2.2M | -26.4% | -3.0% | -3.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.